Humoral Immunogenicity of 3 COVID-19 Messenger RNA Vaccine Doses in Patients With Inflammatory Bowel Disease

Trevor L. Schell; Keith L. Knutson; Sumona Saha; Arnold Wald; Hiep S. Phan; Mazen Almasry; Kelly Chun; Ian Grimes; Megan Lutz; Mary S. Hayney; Francis A. Farraye; Freddy Caldera

doi:10.1093/ibd/izac082

Humoral Immunogenicity of 3 COVID-19 Messenger RNA Vaccine Doses in Patients With Inflammatory Bowel Disease

Trevor L. Schell, Keith L. Knutson, Sumona Saha, Arnold Wald, Hiep S. Phan, Mazen Almasry, Kelly Chun, Ian Grimes, Megan Lutz, Mary S. Hayney, Francis A. Farraye, Freddy Caldera

Jacksonville, FL

Research output: Contribution to journal › Article › peer-review

Abstract

Herein, we evaluated the humoral immunogenicity of a third coronavirus disease 2019 messenger RNA vaccine dose in patients with inflammatory bowel diseases. All patients displayed a humoral immune response, and median antibody concentrations were higher after the third dose than after completion of the 2-dose series.

Original language	English (US)
Pages (from-to)	1781-1786
Number of pages	6
Journal	Inflammatory bowel diseases
Volume	28
Issue number	11
DOIs	https://doi.org/10.1093/ibd/izac082
State	Published - Nov 1 2022

Keywords

COVID-19 vaccine
Crohn's disease
inflammatory bowel disease
ulcerative colitis

ASJC Scopus subject areas

Gastroenterology
Immunology and Allergy

Access to Document

10.1093/ibd/izac082

Cite this

@article{7b58345eb55b48acaab8a3e65a9ea9fb,

title = "Humoral Immunogenicity of 3 COVID-19 Messenger RNA Vaccine Doses in Patients With Inflammatory Bowel Disease",

abstract = "Herein, we evaluated the humoral immunogenicity of a third coronavirus disease 2019 messenger RNA vaccine dose in patients with inflammatory bowel diseases. All patients displayed a humoral immune response, and median antibody concentrations were higher after the third dose than after completion of the 2-dose series.",

keywords = "COVID-19 vaccine, Crohn's disease, inflammatory bowel disease, ulcerative colitis",

author = "Schell, {Trevor L.} and Knutson, {Keith L.} and Sumona Saha and Arnold Wald and Phan, {Hiep S.} and Mazen Almasry and Kelly Chun and Ian Grimes and Megan Lutz and Hayney, {Mary S.} and Farraye, {Francis A.} and Freddy Caldera",

year = "2022",

month = nov,

day = "1",

doi = "10.1093/ibd/izac082",

language = "English (US)",

volume = "28",

pages = "1781--1786",

journal = "Inflammatory bowel diseases",

issn = "1078-0998",

publisher = "John Wiley and Sons Inc.",

number = "11",

}

TY - JOUR

T1 - Humoral Immunogenicity of 3 COVID-19 Messenger RNA Vaccine Doses in Patients With Inflammatory Bowel Disease

AU - Schell, Trevor L.

AU - Knutson, Keith L.

AU - Saha, Sumona

AU - Wald, Arnold

AU - Phan, Hiep S.

AU - Almasry, Mazen

AU - Chun, Kelly

AU - Grimes, Ian

AU - Lutz, Megan

AU - Hayney, Mary S.

AU - Farraye, Francis A.

AU - Caldera, Freddy

PY - 2022/11/1

Y1 - 2022/11/1

N2 - Herein, we evaluated the humoral immunogenicity of a third coronavirus disease 2019 messenger RNA vaccine dose in patients with inflammatory bowel diseases. All patients displayed a humoral immune response, and median antibody concentrations were higher after the third dose than after completion of the 2-dose series.

AB - Herein, we evaluated the humoral immunogenicity of a third coronavirus disease 2019 messenger RNA vaccine dose in patients with inflammatory bowel diseases. All patients displayed a humoral immune response, and median antibody concentrations were higher after the third dose than after completion of the 2-dose series.

KW - COVID-19 vaccine

KW - Crohn's disease

KW - inflammatory bowel disease

KW - ulcerative colitis

UR - http://www.scopus.com/inward/record.url?scp=85134534186&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85134534186&partnerID=8YFLogxK

U2 - 10.1093/ibd/izac082

DO - 10.1093/ibd/izac082

M3 - Article

C2 - 35396992

AN - SCOPUS:85134534186

SN - 1078-0998

VL - 28

SP - 1781

EP - 1786

JO - Inflammatory bowel diseases

JF - Inflammatory bowel diseases

IS - 11

ER -

Humoral Immunogenicity of 3 COVID-19 Messenger RNA Vaccine Doses in Patients With Inflammatory Bowel Disease

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this